Bio-Rad Laboratories (BIO) Shares Outstanding (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Shares Outstanding (Entity) of $25.2 million for Q1 2026, little changed year-over-year from $25.2 million in Q1 2025, and little changed quarter-over-quarter from $25.2 million in Q4 2025.
Bio-Rad Laboratories (BIO) Shares Outstanding (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Shares Outstanding (Entity) for 18 consecutive years, with $25.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) changed 0.02% year-over-year to $25.2 million; the TTM figure through Mar 2026 stood at $25.2 million (changed 0.02% YoY), while the FY2025 annual figure was $25.2 million, changed 0.03% from the prior year.
- Shares Outstanding (Entity) held at $25.2 million in Q1 2026 per BIO's latest filing, from $25.2 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $25.2 million in Q1 2026 and bottomed at $25.2 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $25.2 million across 5 years, with a median of $25.2 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) climbed 0.28% — and 2023, when it climbed 0.01%.
- Bio-Rad Laboratories' Shares Outstanding (Entity) stood at $25.2 million in 2022, then advanced by 0.03% to $25.2 million in 2023, then increased by 0.09% to $25.2 million in 2024, then grew by 0.03% to $25.2 million in 2025, then grew by 0.0% to $25.2 million in 2026.
- Business Quant data shows BIO's Shares Outstanding (Entity) at $25.2 million in Q1 2026, $25.2 million in Q4 2025, and $25.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Bio-Rad Laboratories | 10.08 Bn | 8.46 Bn | 345.80 Mn | 26.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.75 Mn |
| Mar 31, 2026 | 26.96 Mn |
| Dec 31, 2025 | 27.26 Mn |
| Sep 30, 2025 | 26.92 Mn |
| Jun 30, 2025 | 27.23 Mn |
| Mar 31, 2025 | 27.94 Mn |
| Dec 31, 2024 | 28.21 Mn |
| Sep 30, 2024 | 27.95 Mn |
| Jun 30, 2024 | 28.40 Mn |
| Mar 31, 2024 | 28.52 Mn |
| Dec 31, 2023 | 29.21 Mn |
| Sep 30, 2023 | 29.10 Mn |
| Jun 30, 2023 | 29.36 Mn |
| Mar 31, 2023 | 29.60 Mn |
| Dec 31, 2022 | 29.79 Mn |
| Sep 30, 2022 | 29.73 Mn |
| Jun 30, 2022 | 29.79 Mn |
| Mar 31, 2022 | 29.93 Mn |
| Dec 31, 2021 | 29.83 Mn |
| Sep 30, 2021 | 29.81 Mn |